NCT03932045View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of SYB Filler(SF-01) in the Correction of Nasolabial Folds

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

October 8, 2018

Primary Completion Date

September 15, 2020

Study Completion Date

August 12, 2022

Conditions
Nasolabial Folds
Interventions
DEVICE

SYB Filler (SF-01)

Apply up to 1.0 ml of the test device (SF-01) and the contrast device (Ellansé M) to both sides of the nasolabial fold.

DEVICE

Ellansé M

Apply up to 1.0 ml of the test device (SF-01) and the contrast device (Ellansé M) to both sides of the nasolabial fold.

Trial Locations (1)

Unknown

Chung-Ang University Hospital, Seoul

All Listed Sponsors
lead

Samyang Biopharmaceuticals Corporation

INDUSTRY

NCT03932045 - A Study to Evaluate the Safety and Efficacy of SYB Filler(SF-01) in the Correction of Nasolabial Folds | Biotech Hunter | Biotech Hunter